Leukemia, Hairy Cell

Hairy cell leukemia is a type of blood cancer involving the excess production of lymphoytes. Here is the latest research on hairy cell leukemia.

January 19, 2022
Open Access

Severe ARDS Secondary to Legionella Pneumonia Requiring VV ECMO in the Setting of Newly Diagnosed Hairy Cell Leukemia.

Journal of Investigative Medicine High Impact Case Reports
Daniel GormanPhil Dellinger
January 14, 2022
Case Report

[Successful surgical resection of rectal cancer in a patient with relapsed hairy cell leukemia under interferon-α treatment].

[Rinshō ketsueki] The Japanese journal of clinical hematology
Tomomi OkaKenichi Nagai
January 5, 2022

Catalytically active holo Homo sapiens adenosine deaminase I adopts a closed conformation.

Acta Crystallographica. Section D, Structural Biology
Minh Thu MaRaquel L Lieberman
December 23, 2021

A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma.

Current Oncology
Elif YilmazAnita Aggarwal
December 23, 2021
Review

CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.

Current Oncology
John J SchmiegAaron Auerbach
December 14, 2021
Review

How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen.

Current Oncology
José CabeçadasMaria Gomes da Silva
November 24, 2021

Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study.

Blood Advances
Sebastian BöttcherAlberto Orfao
November 15, 2021

[Moxetumomab pasudotox-Third line in Hairy cell leukemia].

Bulletin du cancer
Lydia Montes, Charles Herbaux
November 4, 2021
Case Report

Classic hairy cell leukemia with an aggressive presentation.

Proceedings
Tyler FugereAbhijit Godbole
October 29, 2021

Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.

American Journal of Hematology
Xavier TroussardEdouard Cornet
October 27, 2021

A Method for the Elution of Anti-CD20 With an EDTA/Glycine Acid Solution for Accurate Immunophenotyping of B Lymphocytes Sensitized With Rituximab.

American Journal of Clinical Pathology
Eli Fuentes-ChávezJosé C Jaime-Pérez
October 27, 2021

Precision diagnostics in lymphomas - Recent developments and future directions.

Seminars in Cancer Biology
Larry MansouriRichard Rosenquist
October 16, 2021

Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.

Hematological Oncology
Alessandro BroccoliPier Luigi Zinzani
October 7, 2021
Review

The cure of leukemia through the optimist's prism.

Cancer
Hagop M KantarjianElias J Jabbour
October 5, 2021
Clinical Trial

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.

Blood Advances
Dai ChiharaRobert J Kreitman
October 4, 2021
Case Report

Retinal Manifestation of an Epstein-Barr Virus-Associated Plasma Cell Neoplasm.

Ocular Oncology and Pathology
Eda ArslanMarc Beer
September 22, 2021
Case Report

Rituximab Treatment of Hairy Cell Leukemia in a Patient with Mycobacterium kansasii Infection: A Case Report.

Oncology Research and Treatment
Carlo MümmlerStefan Boeck

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

FLT3 Inhibitors in Acute Myeloid Leukemia

FMS related tyrosine kinase 3 (FLT3) is a frequently mutated receptor tyrosine kinase in Acute Myeloid Leukemia. Novel Tyrosine kinase inhibitors against FLT3 are currently in clinical trial. Discover the latest research on FLT3 Inhibitors in Acute Myeloid Leukemia here.

Hodgkin Disease

Hodgkin disease or Hodgkin's lymphoma is a type of lymphoma that affects the lymph system. Here is the latest research on Hodgkin disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/leukemia-hairy-cell/74522dac-cdf3-4e8f-8367-8e350a669af8